CliffBio
small molecule

ZEMPLAR

PARICALCITOL

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameZEMPLAR
Active ingredientPARICALCITOL
Strength0.005MG/ML (0.005MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 1998
Marketing statusRX

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ZEMPLAR patent cliff — loss of exclusivity — | CliffBio